CO5400144A1 - Compuestos organicos - Google Patents
Compuestos organicosInfo
- Publication number
- CO5400144A1 CO5400144A1 CO03012637A CO03012637A CO5400144A1 CO 5400144 A1 CO5400144 A1 CO 5400144A1 CO 03012637 A CO03012637 A CO 03012637A CO 03012637 A CO03012637 A CO 03012637A CO 5400144 A1 CO5400144 A1 CO 5400144A1
- Authority
- CO
- Colombia
- Prior art keywords
- fine
- grained particles
- animal medicament
- vehicle material
- millimeters
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000002245 particle Substances 0.000 abstract 4
- 239000000463 material Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- 239000012876 carrier material Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02005511 | 2002-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5400144A1 true CO5400144A1 (es) | 2004-05-31 |
Family
ID=27798784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO03012637A CO5400144A1 (es) | 2002-03-11 | 2003-02-14 | Compuestos organicos |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20050169971A1 (enExample) |
| EP (2) | EP1803448A3 (enExample) |
| JP (1) | JP4663985B2 (enExample) |
| KR (1) | KR20040101302A (enExample) |
| CN (1) | CN1652754B (enExample) |
| AR (1) | AR038899A1 (enExample) |
| AT (1) | ATE390129T1 (enExample) |
| AU (1) | AU2003218722B2 (enExample) |
| BR (1) | BR0308378B1 (enExample) |
| CA (1) | CA2478811C (enExample) |
| CO (1) | CO5400144A1 (enExample) |
| DE (1) | DE60319969T2 (enExample) |
| DK (1) | DK1490037T3 (enExample) |
| ES (1) | ES2301784T3 (enExample) |
| MX (1) | MXPA04008845A (enExample) |
| NZ (1) | NZ535167A (enExample) |
| PT (1) | PT1490037E (enExample) |
| RU (1) | RU2318498C2 (enExample) |
| SI (1) | SI1490037T1 (enExample) |
| TW (1) | TWI309557B (enExample) |
| WO (1) | WO2003075895A1 (enExample) |
| ZA (1) | ZA200407010B (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2556169C (en) * | 2004-01-29 | 2011-11-22 | Andrew Lees | Use of amino-oxy functional groups in the preparation of vaccines |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| JP2008502727A (ja) * | 2004-06-10 | 2008-01-31 | グラット エアー テクニクス インコーポレーテッド | 徐放性基材医薬品製剤 |
| WO2005123042A1 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc. | Controlled release pharmaceutical formulation |
| EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| EP1935405A1 (en) * | 2006-12-22 | 2008-06-25 | LEK Pharmaceuticals D.D. | Orally disintegrating tablets |
| KR20140057604A (ko) | 2011-08-12 | 2014-05-13 | 베링거잉겔하임베트메디카게엠베하 | 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제 |
| AU2012307656B2 (en) | 2011-09-15 | 2016-07-07 | Friulchem Spa | Compositions for oral administration to animals, production methods thereof and uses of same |
| CZ308210B6 (cs) * | 2011-11-02 | 2020-03-04 | Veterinární A Farmaceutická Univerzita Brno | Farmaceutická kompozice ve formě pelet majících velikost částic v rozmezí od 0,1 do 10 mm pro perorální podání vodním živočichům a způsob její výroby |
| RU2014129508A (ru) | 2011-12-21 | 2016-02-10 | Новартис Тиргезундхайт АГ | Новая комбинация |
| WO2013135853A1 (en) * | 2012-03-15 | 2013-09-19 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical packaging product for the veterinary medical sector |
| US10398705B2 (en) | 2012-03-15 | 2019-09-03 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| DK179072B1 (da) * | 2012-05-08 | 2017-10-09 | Novartis Tiergesundheit Ag | Ny Behandling |
| FR2991179B1 (fr) | 2012-06-01 | 2016-11-11 | Ceva Sante Animale | Compositions veterinaires orales appetentes |
| CA2883139C (fr) | 2012-08-31 | 2021-08-10 | Friulchem Spa | Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations |
| WO2014053555A1 (en) | 2012-10-04 | 2014-04-10 | Novartis Ag | Veterinary drug system |
| FR3002735B1 (fr) | 2013-03-04 | 2015-07-03 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| FR3002736B1 (fr) | 2013-03-04 | 2015-06-26 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| AU2014292086B2 (en) | 2013-07-19 | 2019-08-08 | Boehringer Ingelheim Vetmedica Gmbh | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| MX375936B (es) | 2013-12-04 | 2025-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Composiciones farmaceuticas mejoradas de pimobendan. |
| KR101687973B1 (ko) * | 2015-12-08 | 2016-12-21 | 주식회사 씨티씨바이오 | 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법 |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
| CN105963270B (zh) * | 2016-06-30 | 2019-01-15 | 齐鲁动物保健品有限公司 | 一种盐酸贝那普利软咀嚼片及其制备方法 |
| CN109673848A (zh) * | 2018-12-29 | 2019-04-26 | 广州智特奇生物科技股份有限公司 | 一种肠溶包被材料、肠道缓释单宁酸及其制备方法 |
| JP7534139B2 (ja) * | 2020-07-03 | 2024-08-14 | 獣医医療開発株式会社 | 動物用医薬製剤 |
| CN112220769A (zh) * | 2020-08-13 | 2021-01-15 | 浙江海正动物保健品有限公司 | 一种米尔贝肟吡喹酮风味片及其制备方法 |
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
| US11529310B2 (en) | 2020-12-08 | 2022-12-20 | Ruminant Biotech Corp Limited | Devices and methods for delivery of substances to animals |
| CN113768038A (zh) * | 2021-09-14 | 2021-12-10 | 江苏省协同医药生物工程有限责任公司 | 一种精准定量实验动物功能性饲料及制备方法与设备 |
| JP7109827B1 (ja) * | 2021-11-16 | 2022-08-01 | 株式会社ハニック・ホワイトラボ | 抗ウイルス剤 |
| CN119033030A (zh) * | 2024-09-03 | 2024-11-29 | 江西省农业科学院畜牧兽医研究所 | 一种提高断奶仔猪生产性能的饲料添加剂 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3231466A (en) * | 1962-10-26 | 1966-01-25 | Walter H Hoffman | Composition and method for treating animals and poultry |
| US3824233A (en) * | 1972-07-06 | 1974-07-16 | Lilly Co Eli | Anthelmintic phenylhydrazones |
| US3937825A (en) * | 1973-09-21 | 1976-02-10 | American Cyanamid Company | Anthelmintic composition and method of use |
| US4708867A (en) * | 1983-12-19 | 1987-11-24 | Key Pharmaceuticals, Inc. | Minipellets |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| JPS63188621A (ja) * | 1987-01-30 | 1988-08-04 | Taisho Pharmaceut Co Ltd | 矯味経口製剤 |
| EP0524180B1 (en) | 1990-04-11 | 1995-04-26 | The Upjohn Company | Taste masking of ibuprofen by fluid bed coating |
| WO1993024109A1 (en) | 1992-06-04 | 1993-12-09 | Smithkline Beecham Corporation | Palatable pharmaceutical compositions |
| SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
| PT760648E (pt) * | 1994-05-20 | 2002-04-29 | Janssen Pharmaceutica Nv | Tabletes de flubendazole de mastigacao para animais domesticos |
| SE9402422D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
| SE9600071D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
| JP4195728B2 (ja) * | 1996-10-16 | 2008-12-10 | ナポ ファーマシューティカルズ，インコーポレーテッド | プロアントシアニジンポリマー止瀉組成物の腸溶製剤 |
| ES2237121T3 (es) * | 1998-07-28 | 2005-07-16 | Takeda Pharmaceutical Company Limited | Preparacion solida disgregable rapidamente. |
| US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
| US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| GB2356346A (en) * | 1999-11-19 | 2001-05-23 | Mars Uk Ltd | Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product |
| US6541025B1 (en) * | 1999-12-30 | 2003-04-01 | Shear/Kershman Laboratories, Inc. | Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
| BR0207948A (pt) | 2001-03-09 | 2004-07-27 | Produits Nestel S A Soc D | Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade |
| US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
-
2003
- 2003-02-14 CO CO03012637A patent/CO5400144A1/es not_active Application Discontinuation
- 2003-03-07 AR ARP030100790A patent/AR038899A1/es not_active Application Discontinuation
- 2003-03-10 MX MXPA04008845A patent/MXPA04008845A/es active IP Right Grant
- 2003-03-10 EP EP06123293A patent/EP1803448A3/en not_active Withdrawn
- 2003-03-10 JP JP2003574170A patent/JP4663985B2/ja not_active Expired - Lifetime
- 2003-03-10 BR BRPI0308378-0B1A patent/BR0308378B1/pt active IP Right Grant
- 2003-03-10 SI SI200331214T patent/SI1490037T1/sl unknown
- 2003-03-10 AT AT03711962T patent/ATE390129T1/de active
- 2003-03-10 TW TW092105075A patent/TWI309557B/zh not_active IP Right Cessation
- 2003-03-10 US US10/506,937 patent/US20050169971A1/en not_active Abandoned
- 2003-03-10 AU AU2003218722A patent/AU2003218722B2/en not_active Expired
- 2003-03-10 ES ES03711962T patent/ES2301784T3/es not_active Expired - Lifetime
- 2003-03-10 WO PCT/EP2003/002446 patent/WO2003075895A1/en not_active Ceased
- 2003-03-10 EP EP03711962A patent/EP1490037B1/en not_active Revoked
- 2003-03-10 CN CN038105713A patent/CN1652754B/zh not_active Expired - Lifetime
- 2003-03-10 CA CA2478811A patent/CA2478811C/en not_active Expired - Lifetime
- 2003-03-10 PT PT03711962T patent/PT1490037E/pt unknown
- 2003-03-10 DK DK03711962T patent/DK1490037T3/da active
- 2003-03-10 NZ NZ535167A patent/NZ535167A/en not_active IP Right Cessation
- 2003-03-10 RU RU2004130433/15A patent/RU2318498C2/ru not_active IP Right Cessation
- 2003-03-10 DE DE60319969T patent/DE60319969T2/de not_active Expired - Lifetime
- 2003-03-10 KR KR10-2004-7014280A patent/KR20040101302A/ko not_active Ceased
-
2004
- 2004-09-02 ZA ZA200407010A patent/ZA200407010B/en unknown
-
2009
- 2009-12-03 US US12/630,422 patent/US8617587B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038899A1 (es) | Un medicamento para animales | |
| ES2044246T3 (es) | Medicamentos con liberacion controlada del producto activo. | |
| ECSP941148A (es) | Medicamento en forma de comprimido con liberacion retardada de substancia activa | |
| Gratia et al. | Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress | |
| AR012596A1 (es) | Comprimidos bio-adhesivos, procedimiento para prepararlos y sus aplicaciones | |
| EA201190300A1 (ru) | Микроэлектрод и множественные микроэлектроды, содержащие устройства для высвобождения лекарственных средств в ткани | |
| AR090143A2 (es) | Composicion farmaceutica para inhibir el crecimiento de celulas anormales | |
| AR022529A1 (es) | Composicion comestible para recubrimientos | |
| UY31205A1 (es) | Composiciones de tabletas de desintegracion oral de lamotrigina | |
| AR046510A1 (es) | Composicion de un antagonista de vegf y un agente anti-proliferativo | |
| AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
| AR053475A1 (es) | Productos alimenticios humedos par amascotas que comprenden una primera capa unida a un alimento base | |
| ATE396712T1 (de) | Pharmazeutische zubereitung zur modifizierten freisetzung | |
| GT200900308A (es) | "complejos de hierro y derivados de carbohidrato solubles en agua, su produccion y medicamentos que contienen los mismos" | |
| Abel et al. | Honey reduces the metastatic characteristics of prostate cancer cell lines by promoting a loss of adhesion | |
| Lagunas-Rangel | Cancer-free aging: Insights from Spalax ehrenbergi superspecies | |
| CO5900010A1 (es) | Composicion farmaceutica estable de glimepirida con liberacion inmediata y metformina con liberacion prolongada | |
| AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
| DK1719503T3 (da) | Anvendelse af stivelse med fraspaltede sidekæder i ekstrudering/sfæronisering af farmaceutiske pellets | |
| DE602006016127D1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
| GB2443793B (en) | Product, method of manufacture and use | |
| WO2016152493A1 (ja) | 吸水処理材及びその製造方法 | |
| US20110064777A1 (en) | Live lactobacillus soap and method for delivering lactobacillus to skin tissue | |
| PE20120182A1 (es) | Extruidos con sustancias activas con forma de agujas | |
| PE20060124A1 (es) | Tabletas de desintegracion que comprenden licarbazepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |